David A. Siegel Alaunos Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$43.8 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.04 - $0.13 $15,764 - $51,233	-394,100 Reduced 91.4%	37,092 $2,000
Q3 2023 Nov 14, 2023	SELL	$0.12 - $0.5 $24,852 - $103,550	-207,100 Reduced 32.45%	431,192 $56,000
Q2 2023 Aug 14, 2023	SELL	$0.43 - $0.65 $379,733 - $574,015	-883,100 Reduced 58.05%	638,292 $325,000
Q1 2023 May 15, 2023	SELL	$0.46 - $0.81 $191,544 - $337,284	-416,400 Reduced 21.49%	1,521,392 $958,000
Q4 2022 Feb 14, 2023	BUY	$0.5 - $261.0 $314,150 - $164 Million	628,300 Added 47.98%	1,937,792 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$1.04 - $322.5 $667,056 - $207 Million	-641,400 Reduced 32.88%	1,309,492 $2.25 Million
Q2 2022 Aug 15, 2022	SELL	$0.41 - $1.24 $322,219 - $974,516	-785,900 Reduced 28.72%	1,950,892 $2.42 Million
Q1 2022 May 16, 2022	SELL	$0.62 - $1.17 $338,706 - $639,171	-546,300 Reduced 16.64%	2,736,792 $1.79 Million
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.89 $2.42 Million - $4.2 Million	2,221,700 Added 209.32%	3,283,092 $3.58 Million
Q3 2021 Nov 15, 2021	BUY	$1.44 - $2.73 $131,904 - $250,068	91,600 Added 9.45%	1,061,392 $1.93 Million
Q2 2021 Aug 16, 2021	BUY	$2.63 - $3.67 $17,358 - $24,222	6,600 Added 0.69%	969,792 $2.56 Million
Q1 2021 May 17, 2021	BUY	$2.82 - $5.6 $209,526 - $416,080	74,300 Added 8.36%	963,192 $3.47 Million
Q4 2020 Feb 16, 2021	BUY	$2.09 - $3.09 $817,817 - $1.21 Million	391,300 Added 78.64%	888,892 $2.24 Million
Q3 2020 Nov 16, 2020	BUY	$2.39 - $3.43 $923,496 - $1.33 Million	386,400 Added 347.51%	497,592 $1.25 Million
Q2 2020 Aug 14, 2020	BUY	$2.2 - $3.71 $60,280 - $101,654	27,400 Added 32.7%	111,192 $365,000
Q1 2020 May 15, 2020	BUY	$1.9 - $4.98 $159,204 - $417,284	83,792 New	83,792 $205,000
Q1 2019 May 15, 2019	SELL	$2.0 - $4.4 $20,000 - $44,000	-10,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.61 - $3.62 $16,100 - $36,200	10,000 New	10,000 $19,000

Others Institutions Holding TCRT

# of Institutions

Shares Held

92.6K

Call Options Held

Put Options Held

View Full List

About Alaunos Therapeutics, Inc.

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

More about TCRT

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account